Gábor Tóth Selected Research

Ecdysteroids

1/2020	Squalenoylated Nanoparticle Pro-Drugs of Adjuvant Antitumor 11α-Hydroxyecdysteroid 2,3-Acetonides Act as Cytoprotective Agents Against Doxorubicin and Paclitaxel.
1/2018	Nitrogen-containing ecdysteroid derivatives vs. multi-drug resistance in cancer: Preparation and antitumor activity of oximes, oxime ethers and a lactam.
1/2017	Backstabbing P-gp: Side-Chain Cleaved Ecdysteroid 2,3-Dioxolanes Hyper-Sensitize MDR Cancer Cells to Doxorubicin without Efflux Inhibition.
12/2013	Synthesis and structure-activity relationships of novel ecdysteroid dioxolanes as MDR modulators in cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gábor Tóth Research Topics

Disease

12	Neoplasms (Cancer) 05/2022 - 12/2013
6	Retinal Degeneration 01/2021 - 11/2005
5	Fuchs' Endothelial Dystrophy 01/2021 - 05/2019
5	Cataract (Cataracts) 01/2021 - 11/2016
4	Wounds and Injuries (Trauma) 01/2021 - 08/2007
4	Keratoconus 10/2020 - 05/2019
3	Corneal Injuries 01/2021 - 01/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 04/2018
3	Breast Neoplasms (Breast Cancer) 02/2020 - 10/2016
2	Glaucoma 01/2021 - 01/2020
2	Corneal Ulcer 10/2020 - 01/2020
2	Hereditary Corneal Dystrophies 10/2020 - 01/2020
2	Lymphoma (Lymphomas) 01/2020 - 01/2018
2	Pain (Aches) 06/2016 - 11/2002
2	Inflammation (Inflammations) 01/2014 - 09/2007
2	Ganglion Cysts (Ganglion) 04/2009 - 11/2005
2	Parkinson Disease (Parkinson's Disease) 04/2009 - 04/2008
2	Ischemia 04/2009 - 11/2005
1	Large Cell Carcinoma 05/2022
1	Adenocarcinoma 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2022
1	Lung Neoplasms (Lung Cancer) 05/2022
1	Hepatocellular Carcinoma (Hepatoma) 05/2022
1	Paraproteinemias (Monoclonal Gammopathy) 03/2022
1	T-Cell Lymphoma (Lymphoma, T Cell) 03/2022
1	Herpetic Keratitis 02/2022
1	Intraoperative Complications 01/2022
1	Edema (Dropsy) 06/2021
1	Liver Neoplasms (Liver Cancer) 03/2021
1	Fibrosis (Cirrhosis) 03/2021
1	Carcinogenesis 03/2021
1	Non-alcoholic Fatty Liver Disease 03/2021
1	Meibomian Gland Dysfunction 01/2021
1	Amblyopia (Lazy Eye) 01/2021
1	Blepharitis 01/2021
1	Burns 01/2021
1	Diabetes Mellitus 01/2021
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Retinal Artery Occlusion 01/2021
1	Retinal Drusen 01/2021
1	Disease Progression 01/2021
1	Epiretinal Membrane (Epiretinal Membranes) 01/2021
1	Carotid-Cavernous Sinus Fistula 01/2021
1	Optic Nerve Injuries 01/2021
1	Corneal Perforation 01/2020
1	Keratitis 01/2020
1	Rupture 01/2020
1	Vision Disorders (Hemeralopia) 01/2020
1	Astigmatism 12/2019

Drug/Important Bio-Agent (IBA)

9	Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)IBA 01/2019 - 11/2002
4	Proteins (Proteins, Gene)FDA Link 05/2022 - 01/2019
4	Pharmaceutical PreparationsIBA 03/2022 - 01/2017
4	EcdysteroidsIBA 01/2020 - 12/2013
4	Sodium Glutamate (Accent)IBA 04/2009 - 11/2005
3	Trastuzumab (Herceptin)FDA Link 02/2020 - 10/2016
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 09/2007
2	Retinaldehyde (Retinal)IBA 01/2021 - 11/2005
2	Blood Glucose (Blood Sugar)IBA 01/2020 - 01/2017
2	AntibodiesIBA 01/2020 - 10/2016
2	NeuropeptidesIBA 02/2019 - 08/2007
2	Morphine (MS Contin)FDA LinkGeneric 02/2012 - 11/2002
2	Neuroprotective AgentsIBA 04/2008 - 08/2007
1	ParaffinIBA 05/2022
1	Formaldehyde (Formol)FDA Link 05/2022
1	Heparitin Sulfate (Heparan Sulfate)IBA 05/2022
1	GlycosaminoglycansIBA 05/2022
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 05/2022
1	ParaproteinsIBA 03/2022
1	Transcription Factors (Transcription Factor)IBA 03/2021
1	CateninsIBA 03/2021
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 03/2021
1	Syndecan-1 (Syndecan 1)IBA 03/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Chimeric Antigen ReceptorsIBA 02/2020
1	Monoclonal AntibodiesIBA 01/2020
1	EpitopesIBA 01/2020
1	ProdrugsIBA 01/2020
1	Dihydrotachysterol (AT 10)IBA 01/2020
1	SteroidsIBA 01/2020
1	SqualeneIBA 01/2020
1	Trypan Blue FDA Link 01/2020
1	SugarsIBA 10/2019
1	Mannose (D-Mannose)IBA 10/2019
1	Oxytocin (Pitocin)FDA LinkGeneric 02/2019

Therapy/Procedure

6	Therapeutics 02/2020 - 09/2007
4	Sutures (Suture) 06/2021 - 12/2018
2	Penetrating Keratoplasty 02/2022 - 01/2020
2	Vitrectomy 01/2021 - 01/2020
2	Injections 01/2021 - 09/2007
2	Corneal Transplantation (Keratoplasty) 10/2020 - 01/2020
2	Trephining 10/2020 - 12/2019
1	Phacoemulsification 01/2022
1	Excimer Lasers 10/2020
1	Ophthalmoscopes 01/2020
1	Transplantation 01/2020